Akiyo Tanabe

4.6k total citations · 1 hit paper
104 papers, 2.3k citations indexed

About

Akiyo Tanabe is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Akiyo Tanabe has authored 104 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Endocrinology, Diabetes and Metabolism, 52 papers in Surgery and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Akiyo Tanabe's work include Adrenal and Paraganglionic Tumors (45 papers), Hormonal Regulation and Hypertension (36 papers) and Pituitary Gland Disorders and Treatments (22 papers). Akiyo Tanabe is often cited by papers focused on Adrenal and Paraganglionic Tumors (45 papers), Hormonal Regulation and Hypertension (36 papers) and Pituitary Gland Disorders and Treatments (22 papers). Akiyo Tanabe collaborates with scholars based in Japan, United States and Pakistan. Akiyo Tanabe's co-authors include Mitsuhide Naruse, Hiroshi Demura, Toshihiro Imaki, Kazue Takano, Kiyoko Naruse, Takanobu Yoshimoto, Tetsuo Nishikawa, Sachiko Takagi, Fumitoshi Satoh and Katsutoshi Takahashi and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Akiyo Tanabe

95 papers receiving 2.3k citations

Hit Papers

Guidelines for the diagnosis and treatment of primary ald... 2011 2026 2016 2021 2011 100 200 300

Peers

Akiyo Tanabe
Akiyo Tanabe
Citations per year, relative to Akiyo Tanabe Akiyo Tanabe (= 1×) peers Jacopo Burrello

Countries citing papers authored by Akiyo Tanabe

Since Specialization
Citations

This map shows the geographic impact of Akiyo Tanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiyo Tanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiyo Tanabe more than expected).

Fields of papers citing papers by Akiyo Tanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiyo Tanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiyo Tanabe. The network helps show where Akiyo Tanabe may publish in the future.

Co-authorship network of co-authors of Akiyo Tanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Akiyo Tanabe. A scholar is included among the top collaborators of Akiyo Tanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiyo Tanabe. Akiyo Tanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Eriko, Kosuke Mukai, Atsunori Fukuhara, et al.. (2024). Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Endocrine Journal. 71(5). 489–497.
2.
Tanabe, Akiyo, et al.. (2024). A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis. PLoS ONE. 19(8). e0308076–e0308076. 1 indexed citations
3.
Ihana‐Sugiyama, Noriko, Kazuo Izumi, Ryotaro Bouchi, et al.. (2023). New‐onset type 1 diabetes and Graves' disease after antiretroviral therapy in a patient with human immunodeficiency virus infection. Journal of Diabetes Investigation. 14(3). 489–493. 2 indexed citations
5.
Izawa, Shoichiro, Kazuhisa Matsumoto, Kazuhiko Matsuzawa, et al.. (2022). Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess. International Journal of Endocrinology. 2022. 1–9. 6 indexed citations
6.
Murakami, Masanori, Kumiko Shiba, Chikara Komiya, et al.. (2022). Heterogeneous circulating miRNA profiles of PBMAH. Frontiers in Endocrinology. 13. 1073328–1073328. 3 indexed citations
7.
Yano, Yuichiro, Yu Hatano, Kouichi Tamura, et al.. (2021). Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. Journal of Human Hypertension. 36(10). 904–910. 4 indexed citations
8.
Naruse, Mitsuhide, Mika Tsuiki, Hironobu Umakoshi, & Akiyo Tanabe. (2015). Clinical practice guideline of pheochromocytoma and paraganglioma. 32(4). 243–245. 2 indexed citations
9.
Tanabe, Akiyo, et al.. (2013). Combination Chemotherapy with Cyclophosphamide, Vincristine, and Dacarbazine in Patients with Malignant Pheochromocytoma and Paraganglioma. Hormones and Cancer. 4(2). 103–110. 55 indexed citations
10.
Watanabe, Daisuke, Akiyo Tanabe, Mitsuhide Naruse, et al.. (2009). Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders. Hypertension Research. 32(9). 807–815. 18 indexed citations
11.
Naruse, Mitsuhide, Akiyo Tanabe, Yoshiko Hara, et al.. (2004). Effects of AT1 Receptor Antagonist and Spironolactone on Cardiac Expression of ET-1 mRNA in SHR-SP/Izm. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S1–S3. 17 indexed citations
12.
Tanabe, Akiyo, Mitsuhide Naruse, Toshiro Seki, et al.. (2000). Hydralazine Decreases Blood Pressure and Endothelin-1 mRNA Expression in Tissues but not Cardiac Weight in SHR-SP/Izm Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S176–S178. 4 indexed citations
13.
Naruse, Mitsuhide, Yoko Ishihara, Akiyo Tanabe, et al.. (2000). Effects of Acute and Chronic Cigarette Smoking on the Expression of Endothelin-1 mRNA of the Cardiovascular Tissues in Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S198–S200. 13 indexed citations
14.
Naruse, Mitsuhide, Akiyo Tanabe, Kiyoko Naruse, et al.. (2000). Augmented Expression of Tissue Endothelin-1 Messenger RNA is a Common Feature in Hypertensive Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S195–S197. 8 indexed citations
15.
Tanabe, Akiyo, Mitsuhide Naruse, Kiyoshi Arai, et al.. (1998). Gene Expression and Roles of Angiotensin II Type 1 and Type 2 Receptors in Human Adrenals. Hormone and Metabolic Research. 30(8). 490–495. 28 indexed citations
16.
Naruse, Mitsuhide, Takanobu Yoshimoto, Akiyo Tanabe, & Kiyoko Naruse. (1998). Pathophysiological significance of the natriuretic peptide system: receptor subtype as another key factor.. Folia Pharmacologica Japonica. 112(3). 147–154. 2 indexed citations
17.
Tanabe, Akiyo, Mitsuhide Naruse, Kiyohito Arai, et al.. (1998). Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells. Journal of Endocrinological Investigation. 21(10). 668–672. 21 indexed citations
18.
Yoshimoto, Taichiro, Mitsuhide Naruse, Z. Zeng, et al.. (1998). The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas. Journal of Endocrinology. 159(2). 247–255. 36 indexed citations
19.
Seki, Toshiro, Mitsuhide Naruse, Kiyoko Naruse, et al.. (1997). Interrelation between nitric oxide synthase and heme oxygenase in rat endothelial cells. European Journal of Pharmacology. 331(1). 87–91. 20 indexed citations
20.
Yoshimoto, Takanobu, Mitsuhide Naruse, Kiyoko Naruse, et al.. (1996). Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.. Endocrinology. 137(3). 1102–1107. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026